Recent advances in hepatitis C virus research and understanding the biology of the virus.
Lunel-Fabiani
Francoise
F
D000998:Antiviral Agents / Q000627:therapeutic use; D035843:Biomedical Research / Q000639:trends*; D018450:Disease Progression; D016679:Genome, Viral; D016174:Hepacivirus / Q000145:classification / Q000235:genetics / Q000472:pathogenicity; D006526:Hepatitis C / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a